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Membrane-active antimicrobial peptides and their synthetic mimics have been studied 
extensively as a new generation of antibiotics to fight against the persistent evolution of 
pathogens that resist traditional antibiotic treatment. It has long been recognized that a delicate 
yet un-quantified balance between amphiphilicity and cationic charge is key to optimize the 
bactericidal efficiency and selectivity of these membrane-active antimicrobials (MAAs). The 
dilemma, however, is that the amphiphilic nature of MAAs that gives rise to their potency in 
disrupting microbial membranes is oftentimes also detrimental to human cells. Hydrophilic 
antimicrobial peptides and polymers generally have good biocompatibility, but they have 
received much less attention due to their low antimicrobial activity. In this work, we investigate 
whether polymer microstructure can be tuned to help hydrophilic polymers acquire high 
antimicrobial activity and selectivity. We evaluate and compare the different antimicrobial 
properties of linear and branched Poly(4-vinyl-N-methylpyridine iodide) (P4MVP) that are both 
hydrophilic and cationic. We show that P4MVP polymers can be designed as potent 
antimicrobial agents with negligible toxicity. We reveal a simple size-dependent antimicrobial 
activity and selectivity relationship that applies to both linear and branched P4MVP polymers. 
We also investigate the antimicrobial mechanism of P4MVP with different microstructures. We 
find that the antimicrobial potency of P4MVP is associated with their ability to remodel 
microbial membrane lipids by inducing a topological transition to form a two-dimensional 
inverted hexagonal structure, where P4MVP chains reside in the middle of the hexagonally 
packed lipid “pores”. Collectively, our results show that it is possible to find another pathway to 
fight against the antibiotics-resistant pathogens by developing hydrophilic and cationic polymers 
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CHAPTER 1 INTRODUCTION AND EXPERIMENT DESIGN 
 
Traditional antibiotics are losing the battle in fighting tough bacterial infections due to the 
rapid spread of bacteria strains that resist one or more antibiotics designed to kill these bacteria. 
According to the Centers for Disease Control and Prevention (CDC) 2013 report,1 more than two 
million people are sickened every year in the United States alone because of the antibiotic-
resistant infections, among which at least 23,000 casualty is directly linked with the failure of 
antibiotic treatment. New generation of antibiotics are urgently needed to fight against the 
persistent evolution of antibiotics-resistant pathogens.  
 
Among all possible candidates of new antibiotics, antimicrobial peptides (AMPs) are 
considered to be one of the most promising choices due to their special antimicrobial 
mechanism. Unlike traditional antibiotics that generally target certain highly specific binding 
sites to disrupt normal bacterial cell metabolism,2-4 AMPs bind to the non-site-specific 
membrane lipids and function by disrupting the bacterial cell membrane.5-10 This special 
mechanism greatly reduces the risks of inducing bacterial resistance, and explains why AMPs are 
still highly effective even though they have coexisted with bacteria for millions of years. 
However, AMPs have limited bio-distribution and often show considerably high toxicity. They 
are also expensive, fragile to environmental stress and subjected to protease degradation. As 
such, AMPs are generally not good choices for clinical antibiotic treatment. 
 
To circumvent those challenges, synthetic mimics of antimicrobial peptides (SMAMPs) have 
attracted a lot of attentions in the past 20 years.11-18 Current efforts on developing SMAMPs can 
be categorized into two major approaches. One approach uses artificial amino acids as the 
building blocks to construct synthetic peptides or peptoids.11,19 Those peptides or peptoids are 
more stable than natural AMPs, but still, massive work is needed and large scale production is 
not realistic. Another more cost-efficient approach uses commercially available monomers as 
building blocks to synthesize antimicrobial polymers by mimicking the two common structural 
characteristics of AMPs, the amphiphilicity and electronpositivity. Different cationic and 
amphiphilic antimicrobial polymers with good biological activity have been synthesized.13,14,17,18 
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Some of the best SMAMPs under development show the same or even better antimicrobial 
activity than AMPs, but are more stable and easier to be produced in large scale.  
 
So far, most of the SMAMP polymers are both amphiphilic and cationic. Even though decent 
antimicrobial activity can be realized by tuning the amphiphilicity, there is always a risk of 
increasing the toxicity as the hydrophobicity is increased. To achieve the best selectivity between 
bacteria and mammalian cells, one has to search extensively and empirically for a compromise 
between the antimicrobial activity and toxicity. As a result, the space to improve the 
antimicrobial selectivity is limited and the process to search for this compromise by repeatedly 
adjusting the amphiphilicity is often times a random walk and very time-consuming.   
 
Despite that most of AMPs are amphiphilic, hydrophilic and cationic AMPs exist in 
nature.20,21 These AMPs usually have negligible toxicity, but their antimicrobial activity is 
generally lower than those of amphiphilic AMPs. As a result, they are much less appreciated by 
researchers. Hydrophilic SMAMP polymers with high antimicrobial activity are very attractive 
candidates for future antibiotics, because they may possess a larger space of improvement on the 
antimicrobial selectivity without having to search relentlessly for a compromise between the 
antimicrobial activity and toxicity. However, very little work has been done in this area and very 
few hydrophilic polymers with high activity have been developed.  
 
On the other hand, microstructure may play an important role on determining the activity and 
selectivity of polymeric SMAMPs, as the linear and branched polymers have very different 
properties due to their different molecular shapes and functional group distributions. Most of the 
polymeric SMAMPs reported so far are linear amphiphilic polymers. Very little attention has 
been paid on the branched amphiphilic polymers, let alone the branched hydrophilic polymers.  
 
To address the gap of knowledge in the development of polymeric SMAMPs, we will 
investigate in this thesis work whether polymer microstructure can be tuned to help hydrophilic 






Figure 1.1 Schematic representation of developing linear and branched hydrophilic cationic 




We will study the structure-activity relationship of linear and branched hydrophilic polymers, 
through which we aim to: 
1) Develop some highly active and biocompatible hydrophilic polymers as an alternative 
pathway to fight against antibiotics-resistant pathogens;  
2) Understand the different antimicrobial properties of linear and branched polymers for the 
rational design of more potent hydrophilic antimicrobial polymers;  
3) Understand the antimicrobial mechanism of novel polymeric SMAMPs that are both 





1.2. Experimental design  
 
We will first develop a model linear amphiphilic and cationic polymer system to study their 
structure and biological activity relationship. Using the same model polymer system, we will 
then study linear polymers that are both hydrophilic and cationic. Their antimicrobial activity 
and toxicity to human cells will be evaluated and compared with their amphiphilic and cationic 
counterparts. To study the role of polymer microstructures, we will synthesize a series of 
branched polymers that are both hydrophilic and cationic using the same polymer model system, 
and compare their biological activity with those of linear polymers. Finally, the antimicrobial 
mechanism will be investigated.  
 
We choose Poly(4-vinyl pyridine) (P4VP) as our model polymer system. By quaternizing 
P4VP with alkyl halides of different alkyl chain lengths, we obtain a model linear polymer 
system with tunable amphiphilicity and cationic charges. For example, by quaternizing P4VP 
with methyl iodide, we obtain Poly(4-vinyl-N-methylpyridine iodide) (P4MVP), a well-known 
hydrophilic and cationic polymer. Increasing alkyl halide chain length in the quaternizing 
reactions leads to the formation of amphiphilic and cationic polymers with increasing 
hydrophobicity. It should be noted that the antimicrobial activities of P4VP-based linear 
polymers quaternized by alkyl halides of different alkyl chain lengths have been examined 
before,22 but these polymers were obtained from commercial sources with poor size control. We 
plan to use Reversible Addition-Fragmentation chain Transfer (RAFT) polymerization, a 
controlled/”living” free radical polymerization method developed in recent ~15 years, to develop 
a model P4VP system with well-defined microstructures. Our reaction design to synthesize linear 



















Figure 1.2 Schematic representation of the synthesis of hydrophilic and amphiphilic P4VP-based 













CHAPTER 2 RELEVANT LITERATURE REVIEW 
 
In this chapter, we give some relevant literature review to introduce antimicrobial peptides 
and their synthetic mimics. The structure-activity of some reported antimicrobial peptides and 
synthetic mimics of antimicrobial peptides is discussed.  
 
2.1. Antimicrobial peptides (AMPs) and synthetic mimics of antimicrobial peptides (SMAMPs) 
 
AMPs exist in plants, invertebrates, humans, and other mammals.7 They are part of the innate 
immune system and generally have broad-spectrum antimicrobial, antifungal, and antiviral 
activity. Despite their ancient lineage, AMPs have remained to be effective antimicrobial agents, 
challenging the general belief that bacteria, fungi and viruses can and will develop resistance to 
any environmental pressure. This long-lasting antimicrobial effectiveness sets AMPs to be the 
hot spot in the process of searching for next generation antibiotics. SMAMPs are the synthetic 
mimics of AMPs that aim to improve the stability and antimicrobial performance of AMPs while 
maintaining a lower cost of production. 
 
2.1.1. Antimicrobial peptides (AMPs) 
 
There are many kinds of AMPs in nature. So far, more than 880 different AMPs have been 
identified or predicted from nucleic acid sequences.8 Even though the diversity of AMPs 
discovered is huge, most of AMPs share two common secondary structural characteristics: 
electronpositivity and amphiphilicity.7,8,10 Examples of AMPs include human α-defensin-3, 
Magainin 2, protegrin and indolicidin, as shown in Figure 2.1A.  
 
The antimicrobial mechanism of AMPs has been extensively studied in the past 
decades.7,10,23,24 The two common secondary structural characteristics are believed to be closely 
associated with their antimicrobial activity and selectivity. As shown in Figure 2.1B, it is 
believed that the positive charge helps AMPs first be absorbed to the negatively charged 
bacterial membrane, and the hydrophobic group then insert into the bacterial membrane to form 
water nanopores or ionic channels, which further leads to the death of bacteria. On the other 
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hand, the interaction between AMPs with the net neutral mammalian cell membrane is much 
weaker, so to some extent, the AMPs can selectively kill bacteria instead of mammalian cells. 
The targets of AMPs are not site-specific and are mostly located on the cell membranes of 
bacteria, which reduces the chance of deactivating AMPs due to mutation, as well as the chance 
of AMPs degradation or modification by enzymes. This membrane-active mode of action evades 
the typical pathways of induced bacterial resistance, which is commonly seen for  traditional 
antibiotics as they target specific metabolic component of bacteria, and explains why it is 
difficult for bacteria to become resistant to AMPs. 
 
 
Figure 2.1 (A) Schematic representation of the structure of human α-defensin-3, Magainin 2, 
protegrin and indolicidin, respectively, where the red part represents the positively charged 
domains and green part represents hydrophobic domains. (B) Schematic representation of 
antimicrobial mechanism of AMPs.7 
 
However, AMPs are too expensive to be used as antibiotics, and they are also fragile to 
environmental stresses, such as pH, temperature and ionic strength, and also subjected to 
protease degradation. 
 
2.1.2. Synthetic antimicrobial peptides and peptoids 
 
One way to improve the stability of AMPs is to develop synthetic AMPs by using artificial 
amino acids as the building blocks. With similar or even better antimicrobial activity and 




There are many different ways to develop synthetic AMPs or peptoids. One way is to replace 
the L-amino acid in natural AMPs with artificial D-amino acid. Shai et al25 synthesized 
diasetereomers of the bee venom melittin by replacing some of L-amino acid in natural melittin 
with D-amino acid as shown in Figure 2.2A. The melittin diastereomers retained the 
antimicrobial activity, while the toxicity to human cells was deprived. Merrifield et al26 replaced 
all L-amino acid in cecropin A, magainin 2 amide and melittin with D-amino acid. All the D 
enantiomers exhibited similar activity with their natural counterparts, but they were more 
resistant to enzymatic degradation.  
 
 
Figure 2.2 Different types of synthetic antimicrobial peptides or peptoids. (A) melittin replaced 
with D-amino acid;25 (B) β-peptides mimicking the structure of magainin;27 (C) cyclic D, L-α-
peptides and their self-assembly structure in membrane;28 (D) oligo-N-substituted glycine based 
peptoids.29  
 
Another way is to synthesize β-peptides instead of α-peptides.27,30,31 Gellman et al27 used β-
peptides to mimic the structure of magainin. The β-peptides have distinct different secondary 
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structure from the natural α-helices magainin and they were more antibacterial active and more 
resistant to protease degradation, as illustrated in Figure 2.2B.  
 
Cyclic peptides were also studied. Ghadiri et al28 developed antimicrobial peptides based on 
six- and eight-residue cyclic D, L-α-peptides, as shown in Figure 2.2C. This antimicrobial was 
protease stable and had broad antibacterial spectrum. 
 
Except for peptides built from natural amino acids, the activity of peptioids built from 
synthetic amino acid mimics was also reported.19,29,32 Barron et al29 used synthesized oligo-N-
substituted glycine based peptoids to mimic magainin-2 amide, as shown in Figure 2.2D. Those 
peptoids exhibited good antibacterial activity and selectivity.  
 
However, even though those synthetic peptides or peptoids are more stable than natural 
AMPs, massive work is required to produce them because they have to be synthesized in a step-
by-step manner. Large scale production is still not realistic. 
 
2.2. Antimicrobial amphiphilic and cationic polymers 
 
Another approach to de novo design of SMAMPs uses commercial available monomers as 
building blocks to synthesize amphiphilic and cationic antimicrobial polymers. The immense 
advantage of polymeric SMAMPs over the previously described peptide-based and peptoid-
based SMAMPs is that they can be obtained in large quantity in very few synthetic steps, 
whereas peptides and peptoids require tedious step-by-step synthesis and typically cannot be 
obtained in large scale. Moreover, polymers are generally more resistant to environmental stress 
and enzymatic degradation than peptides and peptoids.  
 
2.2.1. Biological activity and amphiphilicity 
 
Many different types of antimicrobial polymers have been synthesized and their structure-
activity relationships have been studied, including polymethacrylate derivatives,17,33-36 β-
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lactams,37-40 arylamides,41 urea,42 poly(phenylene ethynylene),43-46 poly(norbornene)47,48 and 
poly(oxanorbornene).49,50 
 
Kuroda and Degrado reported polymethacrylate based amphiphilic and cationic copolymers,33 
as shown in Figure 2.3A. They investigated the structure–property relationship of a series of 
amphiphilic random copolymers with varying monomer content. The results are shown in Figure 
2.3B.  
 
Figure 2.3 (A) Synthesis and structure of random copolymers from n-butyl methacrylate and 
ethylammonium methacrylate; (B) Antimicrobial (MIC) and hemolytic (HC50) activities of (a) 
polymers 1 with Mn of 8–10 kg/mol, (b) polymers 2 with Mn of 4.5–6 kg/mol, (c) polymers 3 
with Mn of 1.3–2 kg/mol, (d) selectivity of polymers 1–3.33 
 
The hydrophilic polymers ha
The antimicrobial activity and toxicity 
increase of toxicity was more remarkable. Thus, even the best 
bacteria over mammalian cells. In a follow
copolymer composition to improve 
antimicrobial activity (8µg/mL)
cationic copolymers were still too toxic to be useful. 
 
Gellman studied the structure and antibacterial activity of 
cationic polymer.37,39,40 Polymers were synthesized by the ring open polymerization of 
monomers that either functionalized with cyclohex
amine as the cationic group,37
Figure 2.4 Structure (A) and antimicrobial activity of nylon
polymers with different compostion 
 
Both antimicrobial activity and 
shown in Figure 2.4B. And the best selectivity was obtained when a so called “balanced 
amphiphilicty” was reached. Further stud
11 
d low antimicrobial activity, but their toxicity was also very low. 
increased with the increase of hydrophobicity. 
polymers had low selectivity for 
-up paper, they varied the hydrophobic groups and the 
antimicrobial activity and selectivity.36
 and selectivity (~13) were obtained, these 
 
Nylon-3 based amphiphilic and 
ane as the hydrophobic group or primary 
 as shown in Figure 2.4A.  
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As we can see from the biological activity of these three types of amphiphilic cationic 
polymers, even though the antimicrobial activity can be improved by tuning the amiphiphilicity, 
there is always a risk that the hemolysis will also be increased drastically. The amphiphilicty 
balanced structure is usually the compromised structure that has modest antimicrobial activity 
and moderate hemolysis. As a result, the space to improve the antimicrobial selectivity is limited.  
 
The hemolysis is usually associated with hydrophobicity: the lower the hydrophobicity, the 
lower the hemolysis. Hydrophilic polymers usually have negligible hemolysis, but their 
antimicrobial activity is generally lower than that of amphiphilic polymers. However, if highly 
active hydrophilic polymers can be developed, they will have a much larger space to improve the 
antimicrobial selectivity than amphiphilic polymers.  
 
2.2.2. Biological activity and molecular weight 
 
For hemolysis, most studies have shown that the increased molecular weight led to increased 
hemolysis.14 Degrado and Kuroda found that polymethacrylate based polymers with Mn of 8–
10kDa was much more hemolytic than that with Mn of 1.3–2kDa,33 as shown in Figure 2.3B. 
Gellman found that when the degree of polymerization (DP) of Nylon-3 based polymers was 
increased, the hemolysis increased drastically, especially when DP reached ~30 units,39 as shown 
in Figure 2.4C. 
 
For the antimicrobial activity, the story is different. Both Kuroda and Gellman found that the 
antimicrobial activity of both polymethacrylate and Nylon-3 based polymers slightly increased 
with the increase of molecular weight,33,39 as shown in Figure 2.3B and Figure 2.4C, 
respectively. But Tew et al found that the antimicrobial activity of polynorbornene based 
polymers slightly decreased with the increase of molecular weight,47 as shown in Figure 2.5B. 
 
There is another interesting feature about the effect of molecular weight on antimicrobial 
activity reported by Tew et al on the study of the structure-activity relationship of 
poly(oxanorbornene ester)-based polymers.49 Even though there was no big difference in the 
antimicrobial activity between polymers with different molecular weight, there was a big 
 
different between oligomers and polymers, as shown in Figure 2.6. Oligomers 
against gram-negative bacteria, but they showed high activity against gram
Polymers, on the other hand, showed high activity against gram
activity against gram-positive bacteria. This is what the
selection between mammalian
negative and gram-positive bacteria. 
 
To sum up, the molecular weight apparently influence
and cationic polymers. Large amphiphilic and cationic polymers 
ones. The antimicrobial activity of 
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activity differs a lot between oligomers and polymers, indicating that the molecular weight d
play a role at the oligomer level.  
 
Figure 2.6 Structure (A) and antimicrobial activity (B) 
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2.3. Hydrophilic AMPs and polymers 
 
Even though most of AMPs have the amphiphilic structure, there are some AMPs with a 
global hydrophilic structure.20,21 Yang evaluated the hydrophobicity of 397 lysine-rich cationic 
AMPs in the antimicrobial peptide database,21 using three established scales: Eisenberg 
consensus, Kyte−Doolittle, and Wimley−White, as shown in figure 2.7a, 2.7b and 2.7c, 
respectively. There were actually a decent amount of antimicrobial active and hydrophilic AMPs. 
For example, Magainin Ⅱ-Q and Magainin Ⅱ-K were the hydrophilic mutants of Magainin Ⅱ, 
but they were both active. On the other hand, some hydrophilic polymers, including 
poly(aminopropyl methacrylamide),35 poly(aminoethyl methacrylate),36 poly(L-lysine),51 ε-poly-
L-lysine,52 and polyguanidinium oxanorbornene53 also demonstrated antibacterial activity of 
varying potency.  Those hydrophilic AMPs and polymers inspire us to explore whether the 
amphiphilicity is really necessary to yield antimicrobial activity. 
 
 
Figure 2.7 Hydrophobicity of 397 lysine-rich antimicrobial peptides, ploted by using three 
established scales (a) Eisenberg consensus, (b) Kyte−Doolittle, and (c) Wimley−White.21 
 
As mentioned before, hydrophilic polymers are very attractive candidates for future 
antibiotics. They are more biocompatible and have a much larger space to improve the 
antimicrobial selectivity than amphiphilic polymers. More and more researchers start to realize 
this point and a few hydrophilic polymers have been studied. Yang studied the biological activity 
of the hydrophilic counterpart of the amphiphilic polymethacrylate based copolymers.21 The 
hydrophobic monomer BMA was replaced with the hydrophilic monomer HEMA and the 
polymer became global hydrophilic, as shown in Figure 2.8A and B. The antimicrobial activity 
of hydrophilic polymers apparently increased with the increase of molecular weight, as shown in 
Figure 2.8C. 
 
Figure 2.8 Structure (A), hydrophobicity 
hydroxyethyl methacrylate) based hydrophilic cationic polymer.
 
Gellman also found that even though that some amphiphilic polymers, polyMM, polyDM and 
poly CHNM (Figure 2.9A), 
polymer, polyNM, was also very active. Beside
better than most of amphiphilic polymers.
 
Figure 2.9 Structure (A) and antimicrobial activity (B) of poly nylon
cationic and amphiphilic cationic polymers.
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2.4. Branched and linear antimicrobial polymers 
 
The linear and branched polymers have different properties due to their different molecular 
shapes and functional group distributions. Most of the antimicrobia
linear amphiphilic polymers. The branched polymers are less studied. Only a few PEI based 
hyperbranched or dendric polymers have been studied. 
 
Moeller studied the biological activity of PEI based hyperbranched amphiphilic polymers 
with different cationic groups and hydrophobic groups
with larger PEI size were found to be less active than polymers with smaller PEI si
larger polymers had higher selectivity due to their low toxicity. 
balanced amphiphilicity was found to be necessary to obtain the best activity and selectivity. 
 
Figure 2.10 Structure of PEI based amphiphilic hyperbranched (A),





,56 as shown in Figure 2
Similar to linear polymers, a
56 dendric (B)
58 
reported so far are 
.10A. Polymers 




57 and linear 
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Cooper and co-workers synthesized PEI based dendric polymers,57 as shown in Figure 2.10B. 
The terminal primary amine was functionalized with different hydrocarbon tails. The 
antimicrobial properties of these dendrimer biocides had a parabolic dependence on molecular 
weight and a balanced amphiphilicity was found to lead to the optimal antimicrobial activity.  
 
Kuroda, on the other hand, reported the antimicrobial activity of hydrophilic linear and 
branched Poly(ethylene imine)s,58 as shown in Figure 2.10C. Linear polymers were found to be 
more active than branched polymers, and both linear and branched polymers were more active 
for S. aureus than E. coli. Since the molecular weight of the polymers varied in this report, it is 
hard to draw a conclusion whether linear PEI polymer was more active than branched ones. 
 
Even though those work showed some preliminary structure-activity relationship of branched 
polymers, the differences between linear and branched polymers were not well-established, due 
to the use of poorly defined polymer structures. Moreover, because of the hyperbranched nature 
of PEI-based polymer, the transition in antimicrobial activity from linear to branched polymers 
was not clear. Thus, to clarify the effect of polymer microstructures on their biological activities, 
a series of simple and well-defined model polymers of systematically varied microstructures and 
sizes are needed. 
 
2.5. Poly(4-vinylpyridine) (P4VP) based antimicrobial polymers 
 
Quaternized P4VPs have been found to be antimicrobial active for decades. Kawabata et al 
reported in 1988 that linear poly(N-benzyl-4-vinylpyridinium salt) was found to exhibit 
antibacterial activity.59 This soluble amphiphilic pyridinium type polymer showed strong 
antibacterial activity against gram-positive bacteria, whereas it was less active against gram-
negative bacteria. It was also found that their antibacterial activity slightly depended on the 
molecular weight.  
 
Tiller et al reported the antimicrobial activity of surface-grafted P4VPs that were quaternized 
with different alkyl group (ethyl, propyl, butyl, hexyl, octyl, decyl, dodecyl, cetyl).22,60 It was 
shown that a balanced amphiphilicity is key: the antimicrobial activity first increased with the 
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increase of alkyl length, but then decreased with the further increase of alkyl length, as shown in 
Figure 2.11.  Polymers with hexyl group had the highest activity. Those polymers were found to 
be active for both gram-negative and gram-positive bacteria.  
 
 
Figure 2.11 Structure and activity of surface grafted P4VPs with different alkyl group.22 
 
Tew et al reported the antimicrobial activity and hemolysis of quaternary pyridinium 
functionalized amphiphilic polyoxanorbornenes.61 A series of polymers with different alkyl 
substituents (ethyl, butyl, hexyl, octyl, decyl and phenylethyl) were prepared, as shown in Figure 
2.12A. When the alkyl tail < 4 carbon, those polymers were neither active nor toxic. But when 
the alkyl tail > 4 carbon, those polymers became both active and toxic, as shown in Figure 
2.12B. As a result, all those amphiphilic polymers had low selectivity. The best selectivity (<50) 
was achieved by polymers quaternized with butyl and hexyl group, again confirming the 
importance of balanced amphiphilicity. The influence of molecular weight on biological activity 
was not significant.  
 
 
Figure 2.12 Structure (A) and activity (B) 
quaternary alkyl pyridinium side chains. 
 
All of those P4VP-based antimicrobial polymers are amphiphilic. 
antimicrobial activity often are
balanced amphiphilicity is needed. As such, the biological activity of hydrophilic P4VP 
quaternized with methyl iodide has never been reported, although recent studies suggest that the 
hydrophilic structure may offer much better selectivity than its amphiphilic counterparts.
 
2.6. Investigation of antimicrobial mechanism by Small Angle X
 
A lot of different methods have been use to investigate the antimicrobial mechanism of AMPs 
and SMAMPs, of which, synchrotron SAXS is regarded to be one of the best methods, because it 
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The ones that show








can reveal detailed information about the interaction between polymers and bacteria membrane 
at a molecular level.  
 
From SAXS profile, three types of information can be extracted: the symmetry of the ordered 
structure, the electron density distribution in the unit cell, and the molecular motions and 
disorder in the sample.62 Lattice symmetry can be directly extracted from the scattering peak 
positions. However, converting the x-ray scattering pattern back to the unit cell structure is not 
straightforward. Here, a brief introduction is given on how to perform this procedure. 
 
The scattering intensity I(q), which can be obtained directly from SAXS profiles, is 
proportional to the scattering amplitude A2(q). A(q) is the Fourier transform of electron density 
ρ(r) in the unit cell.  Therefore, once A(q) is calculated from the SAXS profile, the electron 
density ρ(r) can be obtained by an inverse Fourier transform.  However, since I(q) depends on 
|A(q)|2, the phase information of A(q) is lost during the measurement, which is known as the 
“phase problem” in crystallography. Certain techniques are needed to recover phase information, 
as described in section 3.5.3 and literature.62-64 
 






)( ρρ  
where ρavg is the average electron density of the unit cell, Vc is the volume of the unit cell, and 
A(q)  is the scattering amplitude of scattering vector q.  The average electron density, ρavg, cannot 
be directly determined from the measured x-ray diffraction data alone and simply results in a 
density offset.62,64  For detailed procedure to perform electron density reconstruction, refer to 
section 3.5.3.  
 
Yang studied the antimicrobial mechanism of poly(phenylene ethynylene) based amphiphilic 
cationic oligomers65,66 and polymethacrylate based based amphiphilic cationic polymers.67 The 
lattice symmetry was obtained directly from SAXS profiles, and the electron density distribution 
was recovered by the method mentioned above. As shown in Figure 2.13, poly(phenylene 
ethynylene) based amphiphilic oligomers reconstruct the bacterial membrane mimicking 
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liposomes into a hexagonal phase,65 while polymethacrylate based amphiphilic polymers induced 
the bacterial membrane mimicking liposome into two cubic phases. 67 
 
 
Figure 2.13 (A) Structure of poly(phenylene ethynylene) based amphiphilic oligomers; (B) 
electron density reconstructed from SAXS profile (left) and unit cell model (right);65 (C) 
Structure of polymethacrylate based amphiphilic polymers; (D) The two cubic model according 
to the SAXS profile.67 
 
Some other insight on the interactions between amphiphilic polymers and lipsomes has been 
reported,68,69 but the actual mechanism is not totally clear. Moreover, the investigation of 












CHAPTER 3 MATERIALS AND METHODS 
 
In this chapter, the materials and characterization methods that have been used for the 
synthesis and characterization of Chain Transfer Agents (CTAs) and different polymers were 
first listed. In the following sections, the specific methods to synthesize different CTAs and 
polymers were then discussed. 
 
3.1. Materials and characterization method 
 
According to the purpose and requirement of accuracy of each experiment, the materials used 
were either purified before use or used as received. Different characterization methods, such as 
NMR, UV-vis spectrometer and microplate reader, were used to characterize the chemical 




4-vinylpyridine (4VP, 95%, contain 100ppm hydroquinone as inhibitor) was purified by 
passing through a column filled with activated basic aluminum oxide. 2,2′-azobis(2-
methylpropionitrile) (AIBN) was recrystallized from ethanol and dried in vacuum. 1,1′-
azobis(cyclohexanecarbonitrile) (ACHN) was recrystallized from methanol and dried in vacuum. 
Ethylene glycol (≥99%), trimethylolmethane (97%), pentaerythritol (≥99%), 1-dodecanethiol 
(≥98%),  tricaprylylmethylammonium bromide (≥99%), 4-dimethylaminopyridine (DMAP, 
99%), dicyclohexylcarbodiimide (DCC, 99%), anhydrous dichloromethane (≥99.8%), anhydrous 
dimethylformamide (DMF, ≥99.8%), 1-ethylpiperidine hypophosphite (95%), methyl iodide 
(99%), ethyl iodide (99%), butyl iodide (99%), hexyl iodide (98%), octyl iodide (98%) and 
dodecyl iodide (98%) were purchased from Sigma Aldrich, and used without further purification.  
Sodium hydroxide, 2-propanol, ethyl acetate, tetrahydrofuran (THF) and chloroform are ACS 
grade reagent purchased from Macron Chemicals, and were used as received. Carbon disulfide 
(100%), hexanes (99%) and anhydrous Na2SO4 (99.7%) were purchased from Fisher Scientific 
and used as received. All other reagents or solvents were purchased from Sigma Aldrich and 




E. coli (ATCC 25922) and S. aureus (ATCC25923) were purchased from ATCC, and 
reactivated according to the instruction from ATCC. Human Red Blood Cell (HRBC) was 
purchased from Innovative Research Inc, stored at 4 °C before use. Tryptic Soy broth (TSB) and 
Mueller Hinton (MH) broth were both purchased from BD and used as received.  Dimethyl 
sulfoxide (DMSO, ≥99.5%), potassium phosphate monobasic (KH2PO4, ≥99.0%), triton X-100 
and agar were purchased from Sigma Aldrich and used as received. 1,2-dioleoyl-snglycero-3-
[phospho-rac-(1-glycerol)] (sodium salt) (DOPG), 1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine (DOPE) and 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) were 
purchased from Avanti Lipid and used as received.  
 
3.1.2. Characterization method 
 
The chemical structures of chain transfer agents (CTAs) and polymers were characterized by 
1H NMR (500M JEOL liquid state NMR spectrometer), Fourier transform infrared (FTIR) 
spectrometer (Thermo-Electron Nicolet 4700) and UV-vis spectrometer (Hewlett Packard 8435). 
The optical density of bacteria at 600nm (OD600) was measured by the same UV-vis 
spectrometer. The optical density of bacteria at 560nm (OD560) and the absorbance of 
hemoglobin at 405nm (OD405) were measure by microplate reader (PerkinElmer Victor X5) that 
is equipped with a 560nm optical filter and 405 nm optical filter. The morphology of bacterial 
surface before and after treated with polymers was characterized by Field Emission Scanning 
Electron Microscope (FE-SEM, JEOL JSM7000F). SAXS experiments were performed at the 
Stanford Synchrotron Radiation Laboratory (BL4-2). The electron density reconstruction from 
SAXS profile was performed by Wolfram Mathematica 8. 
 
3.2. Synthesis of RAFT agents 
 
To synthesize the different polymers, a series of chain transfer agents (CTAs) were first 
synthesized. S-1-Dodecyl-S’-(α,α’-dimethyl-α’’-acetic acid) trithiocarbonate (mono-DATC) was 
used to synthesize all linear polymers. di-functionalized DATC (di-DTAC), tri-functionalized 
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DATC (tri-DTAC) and tetra-functionalized DATC (tetra-DATC) were used to synthesize di-
branched, tri- branched, and tetra- branched polymers, respectively.  
 
3.2.1. Synthesis of mono-DATC 
 
mono-DATC was synthesized following a previous report.70 As shown in Figure 3.1, 1-
Dodecanethiol (26.92g, 0.133mol), acetone (64.13g, 1.10mol) and tricaprylylmethylammonium 
bromide (1.71g, 0.0053mol,) were added into a 500mLflask and then placed in an ice bath. 
Sodium hydroxide solution (50%) (11.18 g, 0.14mol) was added dropwise into the solution and 
the reaction was further stirred for another15 min. A mixture of carbon disulfide (10.14g, 
0.133mol) and acetone (13.45g, 0.23mol) was dropped into the flask and the reaction was further 
stirred for 10min. Chloroform (23.75 g, 0.20mol) was then added before the dropwise addition of 
50% sodium hydroxide solution (53.33 g, 0.67mol) over 30 min. The reaction was stirred 
overnight. 200mL DI water and 33mL concentrated HCl were added into the flask in sequence 
and the mixture was stirred for 30min. Acetone was removed by purge N2 into the flask with 
vigrous stirring. The resulting solid was collected by filtration and redissolved by 350mL 2-
propanol. The solution was filtered in hot (~50 °C) to remove any undissolved solid. And the 
filtrate was cooled to 4°C for re-crystallization. The resultant solid was removed by filtration. 2-
propanol was then removed by reduced pressure. The residue brown solution was dissolved by 
hot hexanes and store at -20 °C for re-crystallization. 17.5g yellow crystalline solid was formed 
overnight. The structure was characterized by 1H NMR. 
 
 








3.2.2. Synthesis of di-DATC 
 
di-DATC was synthesized by the esterification of mono-DATC with ethylene glycol, as 
shown in Figure 3.2. In a typical experiment, mono-DATC (1.5g, 4.11mmol) and 4-
dimethylaminopyridine (DMAP, 0.099g, 0.811mmol) was dissolved in 10mL anhydrous CH2Cl2 
and added into a 125mL flask, which was then placed in an ice bath. Dicyclohexylcarbodiimide 
(DCC, 0.89g, 4.3mmol) and ethylene glycol (0.099g, 1.6mmol) were dissolved in 10mL 
anhydrous CH2Cl2 and dropped into the flask over 30min. The reaction was kept in ice bath for 
2h and then room temperature for 10h. The resultant solid was removed by filtration and CH2Cl2 
was removed by reduced pressure. The residue was purified by passing through a SiO2 gel filled 
column and eluted by hexanes/ethyl acetate=15/1. After evaporation of solvent in vacuum, 1.2g 
di-DATC was obtained, 75% yield. The structure was characterized by 1H NMR. 
 
 
Figure 3.2 Scheme for the synthesis of di-DTAC. 
 
3.2.3. Synthesis of tri-DATC 
 
tri-DATC was synthesized in a similar way as di-DATC, but trimethylolmethane was used 
instead, as shown in Figure 3.3. mono-DATC (1.5g, 4.11mmol), DMAP (0.1, 0.820mmol) and 
10mL anhydrous CH2Cl2 were added into a 125mL flask and placed in an ice bath. DCC (0.89g, 
4.3mmol) and trimethylolmethane (0.106g, 1mmol) were dissolved in 10mL anhydrous DMF 
and dropped into the flask over 30min. The reaction was kept in ice bath for 2h and room 
temperature for another 10h. The resultant solid was removed by filtration and solvent was 
removed by reduced pressure. The residue was purified by passing through SiO2 gel column and 
eluted by hexanes/ethyl acetate=15/1. After evaporation of solvent in vacuum, 0.6g tri-DATC 




Figure 3.3 Scheme for the synthesis of tri-DTAC. 
 
3.2.4. Synthesis of tetra-DATC 
 
By esterifying mono-DATC with pentaerythritol using the same synthesis condition as the 
synthesis of tri-DATC, tetra-DATC can be synthesized, as shown in Figure 3.4. However, the 
yield was very low (~1.5%) and it was not cost effective to synthesize it in laboratory. So tetra-
DATC was bought from Sigma Aldrich.  
 
 
Figure 3.4 Scheme for the synthesis of tetra-DTAC. 
 
 
3.3. Synthesis of polymers 
 
All polymers were synthesized by Reversible Addition-Fragmentation Chain Transfer 
(RAFT) polymerization. It is one of the most widely used controlled living radical 
polymerization methods due to its excellent ability in controlling polymerization kinetics and 




3.3.1. Synthesis of linear P4VP polymers 
 
All linear P4VP polymers were synthesized by using mono-DATC as the chain transfer agent 
and AIBN as the initiator. The ratio of DATC/AIBN was always kept to be 8/1. Taking the 
synthesis of P4VP28 as an example (shown in Figure 3.5), mono-DATC (0.2667g, 0.73mmol), 
AIBN (15mg, 0.091mmol) and 4-vinylpyridine (3.84g, 36.6mmol) were dissolved in 3.84g THF 
and added into a 10mL schlenk flask. After degassed by three freeze–evacuate–thaw cycles, the 
reaction was kept in 60 °C for 9h. The polymer solution was diluted by chloroform and 
precipitated into hexanes twice and the final product was dry in vacuum overnight.  
 
 
Figure 3.5 Scheme for the synthesis of P4VP28. 
 
P4VPs with different chain length were synthesized by varying the ratio of monomer/CTA, 
reaction time and monomer concentration. The reaction conditions for all linear P4VP polymers 
were listed in table 3.1. 
 










30 4.4 50/1/0.125 9 56 28a 3305 
60 4.4 100/1/0.125 13.5 58 58b 6455 
90 4.4 100/1/0.125 18 93 93b 10130 
120 4.4 130/1/0.125 28 89 116b 12545 
150 4.4 161/1/0.125 36 95 153b 16430 
a Determined from NMR; b determined by conversion; c Calculated from DP. 
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3.3.2. Synthesis of branched P4VP polymers 
 
All branched P4VP polymers were synthesized by using AIBN as the initiator and their 
molecular weight and number of branches were controlled by corresponding chain transfer 
agents (di-, tri- or tetra-DATC). The DATC units/initiator was kept to be 8/1 for all branched 
P4VP polymers. Taking the synthesis of tri-P4VP32 as an example (shown in Figure 3.6), tri-
DATC (90mg, 0.078mmol), AIBN (5.0mg, 0.03mmol) and 4-vinylpyridine (1.28g, 12.19mmol) 
were dissolved in 1.5g THF and added into a 10mL schlenk flask. After degassed by three 
freeze–evacuate–thaw cycles, the reaction was kept in 60 °C for 9h. The polymer solution was 
diluted by chloroform and precipitated into hexanes twice and the final product was dry in 






























Figure 3.6 Scheme for the synthesis of tri-P4VP29. 
 
The reaction conditions for synthesis different branched P4VPs were listed in table 3.2. 
 
Table 3.2 Reaction conditions for branched P4VP polymers. 









di-P4VP 30 4.1 103/1/0.125 9 62 32a 7476 
 
tri-P4VP 
30 4.1 152/1/0.125 9 57 29a 10254 
60 3.7 200/1/0.125  14 95 63b 20964 
90 3.5 312/1/0.125 24 82 85b 27894 
 
tetra-P4VP 
30 4.1 207/1/0.125 9 64 33a 15385 
60 3.7 270/1/0.125 14 95 64b 28405 
90 3.5 415/1/0.125 24 90 93b 40585 
a Determined from NMR; b determined by conversion; c Calculated from DP. 
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3.3.3. CTA end group removal 
 
When the polymers have been synthesized successfully, the CTA end group was removed by 
the radical-induced reduction,71 which requires a H-donor and a radical initiator. In our work, 1-
ethylpiperidine hypophosphite was used as H-donor and ACHN was used as the radical initiator. 
For all the polymers, the polymer/ H-donor /initiator=1/10/1. Taking the synthesis of P4VP58 as 
an example (shown in Figure 3.7), in a typical run, P4VP58 (0.5g, 0.082mmol), 1-ethylpiperidine 
hypophosphite (150mg, 0.83mmol) and ACHN (20.0mg, 0.083mmol) were dissolved in 3mL 
DMF and added into a 10mL schlenk flask. After degassed by three freeze–evacuate–thaw 
cycles, the reaction was kept in 110 °C for 4.5h. The polymer solution was precipitated in ether 
and re-dissolved by chloroform, which was then extract by DI water twice to remove any water 
soluble byproduct and remaining ethylpiperidine hypophosphite. After dehydrated by anhydrous 
Na2SO4, the chloroform was removed by reduce pressure and the residue polymer solution was 








All polymers were quaternized by methyl iodide to give cationic charge. To make sure that all 
the 4VP units were quaternized, methyl iodide was used 1.5-2 times over that of the 4VP unit. 
Taking the synthesis of P4VP58 as an example (shown in Figure 3.8), in a typical run, P4VP28 
(23.2mg, 0.22mmol 4VP units) were quaternized by CH3I (48.3mg, 0.34mmol) in 1mL DMF. 
After kept in 45°C for 24h, polymer was precipitated into ethyl ether and dried in vacuum. For 
P4VP28 and P4VP58, instead of just quaternized by methyl iodide, the polymers were also 
quaternized by ethyl, butyl, hexyl, octyl and decyl iodide, in order to study the effect of different 




Figure 3.8 Scheme for the quaternization of P4VP28. 
 
The alkyl groups used to quaternize our model polymers were summarized in Table 3.3. 
 
Table 3.3 Summary of polymers quaternized with different alkyl groups. 
Sample name methyl ethyl butyl hexyl octyl decyl 
P4VP28 Y Y Y Y Y Y 
P4VP58 Y Y Y Y Y Y 
P4VP93 Y / / / / / 
P4VP116 Y / / / / / 
P4VP153 Y / / / / / 
P4VP185 Y / / / / / 
di-P4VP32 Y / / / / / 
tri-P4VP29 Y / / / / / 
tri-P4VP63 Y / / / / / 
tri-P4VP85 Y / / / / / 
tetra-P4VP33 Y / / / / / 
tetra-P4VP64 Y / / / / / 
tetra-P4VP93 Y / / / / / 
 
 
3.4. Biological activity  
 
The biological activity includes the antimicrobial activity and the human cell toxicity. Both 




3.4.1. Bacterial inhibitory assay 
 
Gram-negative E. coli and gram positive S. aureus were used as representative bacterial 
strains to evaluate the antimicrobial activity of polymers. The freeze-dried bacterial powder 
purchased from ATCC was reactivated according to the instruction from ATCC. Briefly, 0.5mL 
TSB broth was added to completely hydrate the powder and 50µL suspension was diluted into 
5mL fresh TSB, which was then cultivated in 37°C until OD600≈1.5-1.8 (stationary phase). The 
suspension was diluted to OD600≈0.35 and mixed with equal volume of 20% glycerol. 1mL 
suspension was distributed into each frozen tube and stored in -80°C freezer as the seed lot. The 
remaining suspension was inoculated on TSB agar plates and cultivated in 37°C until visible 
colonies were formed. The plates were kept in 4°C before use and used within two weeks after 
preparation.  
 
The method used to determine the bacterial inhibitory activity was modified from CLSI 
recommendation and literature.72 E. coli or S. aureus were inoculated in MH broth and cultivated 
for 18h at 37 °C, and then diluted into fresh MH broth by 100 fold for re-growth. When OD600 
=0.5-0.6, bacteria suspension was diluted by fresh MH broth to OD600 =0.003, which corresponds 
to ~5×105 CFU/ml (determined by plating the diluted suspension on agar plates). Polymers were 
first dissolved in sterile water as the stock solution. Serial 2-fold dilution of the polymer stock 
solution with sterile water in micro-centrifuge tubes gave the desired series of concentration. To 
each well in preset 96-well microplates, 10 µl diluted polymer solution and 90 µl diluted 
bacterial suspension were added. 90 µl diluted bacterial suspension mixed with 10 µl sterile 
water was used as the positive control, while 90 µl fresh MH broth mixed with 10 µl sterile water 
was used as the negative control. The 96-well microplate was incubated at 37°C for 18 h. After 












ω ,                                         (3.1) 
Where OD560, sample is the optical density of each tested concentration, OD560, PC is the optical 
density of positive control and OD560, NC is the optical density of negative control. The MIC is 
defined as the minimal concentration that completely inhibiting bacterial growth (ω<5%). 
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For polymers that can not directly dissolve in water, DMSO was used to prepare the stock 
solution. The final DMSO concentration was control to be <5%, which was tested to cause no 
harm on the growth of bacteria. All antimicrobial tests were performed two times, each in 
quadruplicate, on different days. 
 
3.4.2. Hemolysis assays 
 
The toxicity of polymers was assessed by their hemolysis against Human Red Blood Cell 
(HRBC). The hemolysis was tested according to the method recommended by CLSI. Polymers 
were first dissolved in sterile water as the stock solution. Serial 2-fold dilution of the polymer 
stock solution with PBS buffer (10mM KH2PO4, 150mM NaCl, pH 7.4) gave desired series of 
polymer concentration. HRBC suspension (300µL) was washed with 12ml buffer and harvested 
via centrifugation at 3,000 rpm (1000g) and then dispersed in 15ml buffer (~1% blood cells). 
The HRBC suspension (160µL) and polymer solution (40µL) were mixed in 1.5mL micro-
centrifugation tubes. The tubes were secured in an orbital shaker, and incubated at 37 °C and 250 
rpm for 60min. PBS buffer(40µL) or Triton X-100 (40µL, 1% v/v), other than polymer solution, 
were added to 160 µL RBC suspension as negative and positive hemolysis controls, respectively. 
The tubes were subsequently centrifuged at 3000rpm (1000g) for 5 minutes. Supernatant (30 µL) 
was diluted with PBS buffer (100 µL) in each well of 96-well microplates. The absorbance at 












ω ,                                              (3.2) 
Where OD405,sample is the absorbance of each tested concentration, OD405,PC is the absorbance of 
the positive control and OD405,NC is the absorbance of the negative control. HC50 is defined as the 
polymer concentration that causes 50% hemolysis. This is commonly regarded as the index of 
toxicity.14  
For polymers that can not directly dissolve in water, DMSO was used to prepare the stock 
solution. The final DMSO concentration was control to be <10%, which was tested to be not 
hemolytic to human red blood cells.  All hemolysis tests were performed two times, each in 
quadruplicate, on different days. 
34 
 
3.5. Antimicrobial mechanism investigation  
 
To understand how polymers kill bacteria, the bacterial surface morphology was characterized 
by FE-SEM. The interaction between polymers and lipids was examined by synchrotron SAXS. 
 
3.5.1. SEM characterization 
 
E. coli and S. aureus were inoculated in MH broth and cultivated for 18h at 37 °C. 40µL 
suspension was diluted into 4mL fresh MH broth for re-growth. When OD600 reached 0.5-0.6, the 
suspension was diluted by 300 times (~5×105 CFU/ml). Certain amount of diluted bacteria 
suspension and polymer solution was mixed to make the final polymer solution slightly smaller 
than MIC. Bacteria incubated without polymer were used as a control. After incubation for 18h, 
bacteria cells were harvested by centrifugation at 5000g for 10 minutes and washed with PBS 
buffer (10mM KH2PO4, 150mM NaCl, pH=7.0) for 2 times and then fixed in PBS containing 
2.5% glutaraldehyde solution for one day. The cells were washed with PBS for three times, 
followed by dehydration using a series of ethanol washes and dried in a lyophilizer.  
 
The bacteria powder sample was placed on a carbon tape, which was mounted onto an aluminum 
stud, and coated with gold prior to SEM analyses. The cells were characterized by an 
accelerating voltage of 20kv with a medium probe current.  
 
3.5.2. SXAS characterization 
 
Most of the cationic antimicrobial polymers kill the bacteria by disrupting their cell 
membrane and we hypothesized that our polymers could also be membrane active. To test this 
hypothesis and also understand their antimicrobial mechanism, the self-assembly of polymers 
with small unilamellar vesicles (SUV) mimicking bacterial and human cell membranes were 
examined by SAXS. 
 
SUVs of different lipid compositions that mimic bacterial or mammalian membranes were 
prepared by sonication method. Briefly, DOPG, DOPE and DOPC stock solution were prepared 
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by chloroform and the chloroform/lipid ratio was adjusted to ~1/80 (w/w). Three lipid mixtures, 
DOPG/DOPE=20/80 (E. coli membrane mimics), DOPG/DOPE/DOPC=20/50/30, 
DOPG/DOPC=20/80 (mammalian cell membrane mimics), were prepared by mixing certain 
amount of lipid stock solution. The chloroform was evaporated by N2 and the lipid was further 
desiccated by vacuum. Millipore water was added to hydrate the lipid films and the final lipid 
concentration was adjusted to be 20mg/ml. After incubated in 37 °C overnight, the lipid solution 
was sonicated by a probe sonicator (Sonics Vibra Cell TM) to clarity and extruded through an 
Avanti mini-extruder set equipped with a polycarbonate membrane (0.1µm pore size) for 11 
times to get uniform SUVs. All experiments were carried out at room temperature, which was 
much higher than the gel-liquid phase transition temperature for any of the component lipids (Tm 
(°C): DOPG, -18; DOPE, -16; DOPC, -20), so there was no phase separation in the SUV 
membranes.65 
 
The polymer-liposome self-assemblies were prepared according to their charge ratio. Three 
different charge ratio were adopted, +/-=5/1, +/-=1/1, +/-=1/2, respectively. The self-assemblies 
were allowed to settle in 4°C for 1-2 days before transferred and sealed into quartz capillaries.  
 
For SAXS experiments at the Stanford Synchrotron Radiation Laboratory (BL4-2), 
monochromatic X-ray with beam energy of 9.0keV was used. The sample to detector distance 
was 1.7m and the radiation time was adjusted according the sample amount and scattering 
intensity, 5-15s were used for most of sample. No radiation damage was observed for the 
exposure times used.  
 
3.5.3. Electron density profile reconstruction 
 
For a powder sample of crystals, the x-ray scattering pattern is a set of discrete concentric 
rings with each ring corresponding to a scattering vector q.  The integrated intensity of each ring, 
Iint(q), and its scattering amplitude Ah,k are related by 
2
,int )()()( khsc AqLmqImqI ⋅⋅∝⋅=  




For the two-dimensional hexagonal phase, when h or k equal to 0 or h =k, the multiplicity for 
the Ah,k is 6. For the remaining cases, the multiplicity is 12.
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The sign of the amplitude Ah,k depends on the phase choice. For the two-dimensional hexagonal 
phase, the most acceptable phasing choice was (+--++++) according to the phasing criteria 
developed by Turner and Gruner.62 
 










































B =  , a is the repeat spacing of the crystal  and Ah,k 
is the amplitude.62,64 
 
The relative electron density can be subsequently normalized to absolute electron density 
values ρhex,Ab by 
cb hexAbhex +⋅= Re,, ρρ                                                                                                                  (3.5) 
Where, b and c are two constants that can be determined if the sample composition and the 





CHAPTER 4 RESULTS AND DISCUSSION 
 
In this chapter, the synthesis and characterization of different CTAs and polymers were first 
discussed. The structure-activity of different polymers was studied and their antimicrobial 
mechanism was also investigated.  
 
4.1. Characterization of CTAs and polymers 
 
CTAs were characterized by NMR. And polymers were characterized by NMR, FTIR and 
UV-vis spectrometer.  
 
4.1.1. Characterization of CTAs 
 
The NMR of mono-, di-, tri-, tetra-DATC were shown in Figure 3.1. 
 
The NMR spectrum for mono-DATC in CDCl3 was shown in Figure 3.1A. Four peaks were 
identified: δ (ppm) =0.87 (3H, CH2-CH3), 1.25 (18H, 9×-CH2-), 1.72 (8H, C-(CH3)2 and -CH2-
CH2-S-) 3.27 (2H, -CH2-CH2-S-). Those H numbers were in good agreement with the theoretical 
structure of DATC.  
 
Figure 3.1B was the NMR spectrum for di-DATC in CDCl3. Five peaks were identified: δ 
(ppm) =0.87 (6H, 2×CH2-CH3), 1.24 (38H, 2×9×-CH2-), 1.72 (18H, 2×C-(CH3)2, 2×-CH2-CH2-
S-), 3.25 (4H, 2×-CH2-CH2-S-), 4.29 (4H, -O-CH2-CH2-O-). Except for the H numbers in δ 
(ppm) =1.72 and 1.25, which were slightly higher than theoretical value, the other H numbers fit 
perfectly the theoretical structure of DATC. The deviation from theoretical H numbers when δ 
(ppm) =1.72 and 1.25 was probably from the residual hexane solvent.  
 
Figure 3.1C showed the NMR spectrum for tri-DATC in CDCl3. Six peaks were identified: δ 
(ppm) =0.87 (12H, 3×CH2-CH3), 1.24 (61H, 3×9×-CH2-), 1.68 (25H, 3×C-(CH3)2, 3×-CH2-CH2-
S-), 2.43 (1H, CH-(CH2)3), 3.25 (6H, 3×-CH2-CH2-S-), 4.05 (6H, 3×-O-CH2-CH-). When δ 
(ppm) >1.68, the H numbers fit perfectly the theoretical structure of tri-DATC. But when δ 
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(ppm) <1.68 the H numbers were slightly higher than theoretical value, which was probably due 
to the residual hexane solvent.  
 
The NMR spectrum for tetra-DATC in CDCl3 was shown in Figure 3.1D. Five peaks were 
identified: δ (ppm) =0.87 (12H, 4×CH2-CH3), 1.24 (76H, 4×9×-CH2-), 1.66 (32H, 4×C-(CH3)2, 
4×-CH2-CH2-S-), 3.27 (8H, 4×-CH2-CH2-S-), 4.00 (8H, 4×-O-CH2-CH-). Except for the H 
numbers in δ (ppm) =1.24, which were slightly higher than the theoretical value, the other H 
numbers fit perfectly the theoretical structure of tetra-DATC. The deviation from theoretical H 
numbers when δ (ppm) =1.24 was probably from the calculation error, since the H atom numbers 
differ a lot between those at δ (ppm) =1.24 and δ (ppm) =4.00. 
 
 




4.1.2. Characterization of linear P4VP polymers 
 
All linear P4VP polymer samples were characterized by NMR, UV-vis and FTIR to make 
sure that the right structure was obtained.  
 
The NMR spectrum of P4VP28 was shown in Figure 3.2A. The degree of polymerization 
(DP) was determined by comparing the number of H atoms at δ (ppm) =8.32, which came from 
4VP units, with those at δ (ppm) =3.23, which came from the CTA end. There were 56.9 H 
atoms at δ (ppm) =8.32 and 2 atoms at δ (ppm) =3.23, so average DP=28 was determined for this 
sample. The same method was used to determine the DP for all other linear P4VP polymers, see 
table 3.1.  
 
 
Figure 4.2 Characterization of P4VP28. (A) NMR spectrum of P4VP-CTA; (B) UV-vis 
absorbance before (black) and after (red) reduction of CTA end group; (C) FTIR spectrum before 




When model P4VPs with desirable sizes have been synthesized, the CTA end was no longer 
needed and it was removed to eliminate any side effect on the biological activity of polymers. 
Figure 3.2B showed that the UV-vis absorbance of P4VP28 before and after end group 
reduction. Before reduction, there was a strong absorbance at λ=309nm, due to the C=S double 
bond of the CTA end group. After reduction, the absorbance completely disappeared, indicating 
that the C=S double bond was reduced and the CTA end group was removed.  
 
The degree of quaternziation (DQ) was characterized by FTIR. Figure 3.2C was the FTIR 
spectrum for P4VP28 before and after quaternization by CH3I. Before the quaternization, three 
peaks at 1597, 1557, and 1415 cm-1 were identified as the characteristic peaks of 4VP, due to 
pyridyl ring-stretching vibrations. After the quaternization, these three characteristic peaks were 
collectivey shifted to higher wavelength number positions characteristic of 4MVP, indicating 
that all of the 4VP units were quaternized by CH3I and the DQ was determined to be 100%. The 
DQ for all linear P4VP polymers quaternized either by CH3I or other alkyl iodide was listed in 
Table 3.3.  
 
The DQ can also be characterized by NMR. The NMR spectrum of P4MVP28 was shown in 
Figure 3.2D. The DQ was determined by comparing the number of H atoms at δ (ppm) =8.78, 
which came from 4VP units, with those at δ (ppm) =4.22, which came from the methyl iodide. 
There were 56.9 H atoms at δ (ppm) =8.32 and 85.6 atoms at δ (ppm) =4.22, and the ratio was 
1/1.5, indicating that all of the 4VP units were quaternized by CH3I and the DQ was determined 
to be 100%. 
 
4.1.3. Characterization of branched P4VP polymers 
 
All branched P4VP polymers sample were also characterized by NMR, UV-vis and FTIR. 
 
The NMR spectrum of tri-P4VP29 was shown in Figure 3.3A. The DP in each branch was 
determined by comparing the number of H atoms at δ (ppm) =8.31 with those at δ (ppm) =3.23. 
There were 57.1 H atoms at δ (ppm) =8.32 and 2 atoms at δ (ppm) =3.23, so an average DP=29 
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was determined for this sample. H atoms at δ (ppm) =3.72 can also be used to determine the DP. 
For consistency, H atoms at δ (ppm) =3.23 were preferred. The DP for other branched P4VP was 
listed in Table 3.2.  
 
UV-vis was again used to confirm that the end group was totally removed. Figure 3.3B 
showed that the UV-vis spectrum of tri-P4VP29 before and after end group reduction. According 
to the figure, the absorbance at λ=309nm completely disappeared, indicating that the CTA end 
group was successfully removed.  
 
 
Figure 4.3 Characterization of tri-P4VP29. (A) NMR spectrum of tri-P4VP-CTA; (B) UV-vis 
absorbance before (black) and after (red) reduction of CTA end group; (C) FTIR spectrum before 
(black) and after (red) quaternization by methyl iodide; (D) NMR spectrum of tri-P4MVP29. 
 
The DQ was characterized by FTIR. Figure 3.3C was the FTIR spectrum of tri-P4VP29 
before and after quaternization by CH3I. The three characteristic peaks were collectively shifted 
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to higher wavelength number positions after the quaternization, indicating that the DQ was 
100%. The DQ for all branched polymers was listed in Table 3.3. 
 
The DQ was also characterized by NMR. The NMR spectrum of tri-P4MVP29 was shown in 
Figure 3.3D. DQ was determined by comparing the number of H atoms at δ (ppm) =8.76, which 
came from 4VP units, with those at δ (ppm) =4.24, which came from the methyl iodide. There 
were 57.1 H atoms at δ (ppm) =8.32 and 85.7 atoms at δ (ppm) =4.22, and the ratio was 1/1.5, 
indicating that all of the 4VP units were quaternized by CH3I and the DQ was determined to be 
100%. 
 
4.2. Biological activity 
 
To show the advantages of hydrophilic polymers, the biological activity of linear amphiphilic 
polymers and linear hydrophilic polymers was first evaluated and compared. And the structure-
activity of branched polymers was also studied, to understand the role of microstructure.  
 
4.2.1. Antimicrobial activity of linear amphiphilic and cationic P4VP polymers quaternized 
with different alkyl groups. 
 
We first studied the structure-antimicrobial activity relationship of amphiphilic and cationic 
polymers. Both P4VP28 and P4VP58 were quaternized by ethyl, butyl, hexyl, octyl, and decyl 
iodide, respectively. Those long hydrocarbon side groups and the cationic charge gave the 
polymer amphiphilic structure. The antimicrobial activity of those amphiphilic polymers were 
evaluated by E.coli and S.aureus.  
 
When fighting against E.coli, both P4VP28 based polymers (figure 3.4A) and P4VP58 based 
polymers (Figure 3.4C) showed similar antimicrobial trend. Polymers quaternized with ethyl and 
butyl iodide, such as P4EVP28, P4BVP28, P4EVP58 and P4BVP58, were not active, with MIC 
> 512µg/mL. Those polymers were still too hydrophilic to be active, even though they already 
had an amphiphilic structure. The more hydrophobic polymers, P4HVP28 and P4HVP58, 
showed potent antimicrobial activity, with MIC =12 and 24µg/mL, respectively. The high 
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antimicrobial activity of these two polymers maybe attributed to their balanced amphiphilicity. 
Further increase the hydrophobicity led to decreased or even lost antimicrobial activity, such as 
P4OVP28, P4DVP28, P4OVP58 and P4DVP58, which may due to the poor water solubility of 
these hydrophobic polymers. These observations are in agreement with what have been reported 
before: the antimicrobial activity first increases with the increase of hydrophobicity to a 
maximum point, after which, the antimicrobial activity decreases with the increase of 
hydrophobicity. A balanced amphiphilicity is required to reach the optimal activity.  
 
 
Figure 4.4 Antimicrobial activity of linear P4VP quaternized with different alkyl groups. The 
MIC of P4EVP28 (red), P4BVP28 (green), P4HVP28 (blue), P4OVP28 (cyan), and P4DVP28 
(purple) against E.coli (A) and S.aureus (B). The antimicrobial activity of P4EVP58 (red), 
P4BVP58 (green), P4HVP58 (blue), P4OVP58 (cyan), and P4DVP58 (purple) against E.coli (C) 
and S.aureus (D). 
 
When tested with S.aureus, the story became different. For P4VP28 polymers, polymer 
quaternized by hexyl iodide was still more active than polymers quaternized by ethyl/butyl 
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iodide and polymers quaternized by octyl/decyl iodide, which again supported the point that a 
balanced amphiphilicity led to the optimal activity. However, for P4VP58 polymers, polymers 
quaternized by ethyl, butyl and hexyl iodide were all active similarly, and they were more active 
than the hydrophobic polymers. Even though the balanced amphiphilicity recognition still makes 
sense, the high antimicrobial activity of P4EVP58 and P4BVP58 gives rise to three questions: 
Why the relatively hydrophilic polymers are also active? Is the amphiphiliciy really necessary 
for polymers to be active? Can we make hydrophilic cationic polymers that are also 
antimicrobial active? 
 
On the other hand, even though the amphiphilicity balanced P4HVP28 and P4HVP58 showed 
the highest activity, but their toxicity was also very high, as will be discussed in detail in section 
4.2.4. While the toxicity of relatively hydrophilic polymers P4EVP58 and P4BVP58 was very 
low even at high polymer concentration, which makes it more necessary to develop hydrophilic 
and cationic polymers.  
 
4.2.2. Activity of linear hydrophilic and cationic P4MVP polymers with different chain length 
 
The relatively hydrophilic amphiphilic P4EVP58 and P4BVP58 showed good antimicrobial 
activity and selectivity against S. aureus, indicating that hydrophilic polymers can also be 
antimicrobial active. In this section, hydrophilic cationic polymers were synthesized by 
quaternizing different linear P4VP polymers with methyl iodide. The antimicrobial activity of 
hydrophilic cationic polymers of six different sizes, P4MVP28, P4MVP58, P4MVP93, 
P4MVP116, P4MVP153 and P4MVP185, was evaluated by E.coli and S. aureus. 
 
When interacted with E.coli (Figure 3.5A), the hydrophilic and cationic P4MVP28 was 
inactive with MIC >512µg/mL, which supports previous recognition that a balanced 
amphiphilicity is key to antimicrobial activity. However, when the polymer size was doubled, the 
polymer P4MVP58 became very active with MIC reaching 48µg/mL. Further increase of 
polymer size first increased the antimicrobial activity to a maximum point and then decreased a 
little bit until reached a plateau, with MIC =24, 12, 24 and 24µg/mL for P4MVP93, P4MVP116, 
P4MVP153, and P4MVP185, respectively.  
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For S.aureus (Figure 3.5B), all the linear hydrophilic and cationic P4MVP polymers were 
highly active, with MIC =24, 6, 6, 6, 6 and 12µg/mL for P4MVP28, P4MVP58, P4MVP93, 
P4MVP116, P4MVP153 and P4MVP185 respectively. The increase of polymer size first 
increased the antimicrobial activity, but the antimicrobial activity quickly reached a plateau that 
no longer change with the polymer size. A slightly decrease in activity was observed for 
P4MVP185.  
 
Our results showed that the hydrophilic and cationic polymers can also be highly active for 
both gram-negative and gram-positive bacteria as long as they have the right size, and their 
activity was comparable with the those polymers with an optimized amiphiphilicity balance. This 
result confirmed our hypothesis that in addition to amphiphilic and cationic structure, 
hydrophilic and cationic polymers can also be designed as antimicrobial agents. Amphiphilic and 
cationic structure is an important factor for the antimicrobial activity, but it is not the only factor.  
 
 
Figure 4.5 Antimicrobial activity of linear hydrophilic cationic polymers. The MIC of P4MVP28 
(red), P4MVP58 (green), P4MVP93 (blue), P4MVP116 (cyan), P4MVP153 (purple) and 
P4MVP185 (yellow) against E.coli (A) and S.aureus (B). 
 
To understand why there is a transition from inactive to highly active for E.coli just by 
increasing the polymer size and why the polymers are more active to S.aureus than E.coli, we 
need to examine the differences in the bacterial membrane structure. For gram-negative bacteria 
E.coli, it has two lipid bilayers underneath sandwiching a very loose and thin 
lipopolysaccharides cell wall. But for gram-positive bacteria S. aureus, it has only one lipid 
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bilayer covered by a dense and thick peptidoglycan cell wall. Suppose that the hydrophilic and 
cationic polymers are also membrane active molecules ,to kill E.coli, polymers need to be long 
enough to span across two lipid bilayers and more polymers are needed to disrupt two layers of 
membranes. That’s why the transition exists and a relatively large quantity of polymers is 
needed. To kill S. aureus, shorter polymers are already long enough to span across the only lipid 
bilayer and less polymers are needed. That may explain why short P4MVP polymers are also 
active and why all P4MVP polymers are more active more active for S. aureus than E.coli.  
 
The effect of polymer size on antimicrobial activity was previous reported in amphiphilic 
cationic polymers, but such a remarkable transition from inactive to active by just controlling the 
chains size was not reported before. The activity of amphiphilic and cationic polymers depends 
primarily on their amphiphilicity not the chain sizes. However, the activity of hydrophilic and 
cationic polymers greatly depends on their chain sizes. This transition is of great significance, 
because we can develop polymers with double antimicrobial selectivity: long hydrophilic 
cationic polymers kill both gram-negative and gram-positive bacteria, while short hydrophilic 
cationic polymers selectively kill gram-positive bacteria; at the same time, they both cause the 
least toxic effect on mammalian cells because of the lack of hydrophobicity.  
 
4.2.3. Activity of branched hydrophilic cationic P4MVP polymers with different chain length 
 
Most of antimicrobial polymers were linear polymers. The structure-activity relationship of 
branched polymers was rarely reported. Here we evaluate the antimicrobial activity of tri-
branched and tetra-branched hydrophilic cationic P4MVP polymers.  
 
Similar to linear P4MVP polymers, the transition in antimicrobial activity was observed when 
the branched polymers interacted with E.coli (Figure 3.6A). When the branch P4VP size was 
~30 units, neither tri-P4MVP29 nor tetra-P4MVP33 were active (MIC >512µg/mL). But if the 
branch size was increased to >60 units, both tri-branched and tetra-branched polymers became 
very active, with MIC=96µg/mL for tri-P4MVP63 and tetra-P4MVP64 and MIC=24µg/mL for 
tri-P4MVP85 and tetra-P4MVP93. Those results confirmed our previous conclusion than long 




For middle P4MVP size (~60 units) in each branch, the antimicrobial activity of branched 
polymers was lower than that of linear polymers. For example, both tri-P4MVP63 and tetra-
P4MVP64 had a MIC =96µg/mL, while P4MVP58 had a MIC =48µg/mL.  However, for long 
P4VP size (~90 units) in each branch, the antimicrobial activity of branched polymers was the 
same as that of linear polymers. For example, tri-P4MVP85, tetra-P4MVP93 and P4MVP93 all 
had a MIC =24µg/mL. The reason for the different antimicrobial performance of linear and 
branched polymers is unknown yet. But we can get some clue by thinking about how do those 
polymers kill bacteria. Again, suppose that the hydrophilic and cationic polymers are membrane 
active molecules. To kill the bacteria, polymers need to reorganize the bacteria membrane. When 
the polymer size is not sufficient long, the polymers need to change their morphology (i.e. 
rotation, bending) to span over two lipid bilayers. The linear polymers have a higher degree of 
freedom to change their shape than branched polymers, so they have a higher antimicrobial 
activity. When the polymer size is sufficiently long, both linear and branched polymers can 
easily span over two lipid bilayers without having to be limited by their degree of freedom. As a 
result, they have similar activity. 
 
 
Figure 4.6 Antimicrobial activity of branched hydrophilic cationic polymers. The MIC of tri-
P4MVP29 (red), tri-P4MVP63 (green), tri-P4MVP85 (blue), tetra-P4MVP33 (cyan), tetra-
P4MVP64 (purple) and tetra-P4MVP93 (yellow) against E.coli (A) and S.aureus (B). 
 
The antimicrobial activity of tri-branched and tetra-branched hydrophilic and cationic 
polymers depends on their size of their branch, but not the number of branches. When the branch 
size was the same, both tri-branched and tetra-branched polymers had the same activity. The 
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structure-activity relationship of those well-define simple branched polymers fill the gap 
between linear and hyperbranched/dendric polymer systems.  
 
The antimicrobial activity of branched polymers against S.aureus (figure 3.6B) showed 
almost the same results as those of linear P4MVP polymers. The antimicrobial activity first 
increased with the increase of polymer size and quickly reached a plateau. No difference was 
observed between linear and branched polymers, indicating that all the three branch sizes were 
long enough to kill S. aureus. Those results once again confirmed the relationship we have 




The toxicity of polymers was assessed by their hemolysis and HC50 was defined as the 
polymer concentration which causes 50% hemolysis, the lower HC50, the higher toxicity.  
 
The hemolysis of P4VP28 quaternized with different alkyl group and P4VP58 quaternized 
with different alkyl group were shown in Figure 3.7A and Figure 3.7B, respectively. For inactive 
polymers quaternized with ethyl and butyl, very low toxicity was found, with HC50 > 
1000µg/mL. However, for polymers quaternized with hexyl, even though they were highly 
active, they were also highly toxic, with HC50=32µg/mL and 8µg/mL for P4HVP28 and 
P4HVP58, respectively. Also a result, the selectivity (HC50/ MIC) of P4HVP28 and P4HVP58 
was very lower. For polymers quaternized by octyl and decyl, their toxicity was very high, with 
HC50<1 µg/mL for P4OVP28, P4DVP28, P4OVP58 and P4DVP58. Consequently, their 
selectivity was <<1. These results confirmed previous observation that the higher the 
hydrophobicity, the more toxic the polymers become. The effort to optimize their antimicrobial 
activity by optimizing amphiphilic balance is seriously limited by the increase of toxicity that 
simply scales with the hydrophobicity. 
 
The hemolysis of linear hydrophilic and cationic P4MVP polymers was shown in Figure 
3.7C. Regardless of the polymer size, all polymers showed nearly negligible hemolysis for all 
tested concentration and the HC50 was never reached, indicating that linear hydrophilic and 
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cationic P4MVP polymers have very low toxicity. As a result, the antimicrobial selectivity for 
active P4MVP polymers is excellent.  
 
 
Figure 4.7 Hemolysis of polymers. Hemolysis of P4VP28 based amphiphilic cationic polymers 
(A), P4VP58 based amphiphilic cationic polymers (B), linear hydrophilic cationic P4MVP 
polymers (C) and branched hydrophilic cationic P4MVP polymers (D). 
 
The hemolysis of branched P4MVP polymers that are both hydrophilic and cationic was 
shown in Figure 3.7D. Except for di-P4MVP31, all branched polymers have negligible 
hemolysis at all tested concentration. The di-P4MVP31 somehow exhibited moderate hemolysis 
when the polymer concentration was >250µg/mL, the reason is unknown. But still, the HC50 was 
never reached even at the highest tested concentration (1000µg/mL). The antimicrobial 




The MIC, HC50 and selectivity for polymers discussed above were summarized in table 4.1 
 
Table 4. 1 Summary of MIC, HC50 and selectivity for all tested polymers.  

















P4EVP28 >512 64 >1024 N.A >16 >8 
P4BVP28 >512 96 >1024 N.A >10 >5 
P4HVP28 12 6 32 3 5 2 
P4OVP28 192 128 <1 <<1 <<1 1.5 
P4DVP28 >512 128 <1 <<1 <<1 >4 
P4EVP58 >512 12 >1024 N.A >85 >42 
P4BVP58 >512 12 >1024 N.A >85 >42 
P4HVP58 24 12 8 <1 <1 2 
P4OVP58 >512 512 <1 <<1 <<1 >1 
P4DVP58 >512 512 <1 <<1 <<1 >1 
P4MVP28 >512 24 >1024 N.A >42 >21 
P4MVP58 48 6 >1024 >21 >171 8 
P4MVP93 24 6 >1024 >42 >171 4 
P4MVP116 12 6 >1024 >83 >171 2 
P4MVP153 24 6 >1024 >42 >171 4 
P4MVP180 24 12 >1024 >42 >85 2 
di-P4MVP32 48 6 >1024 >21 >171 8 
tri-P4MVP29 >512 12 >1024 N.A >85 >42 
tri-P4MVP63 96 6 >1024 >11 >171 16 
tri-P4MVP85 24 6 >1024 >42 >171 4 
tetra-P4MVP33 >512 12 >1024 N.A >85 >42 
tetra -P4MVP64 96 6 >1024 >11 >171 16 
tetra -P4MVP93 24 6 >1024 >42 >171 4 
Selectivity (E.coli vs RBC): selectivity between E.coli and RBC, HC50/MICE.coli;  
Selectivity (S.aureus vs RBC): selectivity between S.aureus and RBC, HC50/MICs.aureus; 
Selectivity (S.aureus vs E.coli): selectivity between S.aureus and E.coli, MICE.coli/ MICs.aureus 
51 
 
4.3. Antimicrobial mechanism 
 
We have shown that hydrophilic and cationic polymers are also potent antimicrobial 
materials. The next question is: how do those hydrophilic polymers kill bacteria? To understand 
this question, the cell surface morphology was characterized by Field-Emission SEM (FE-SEM) 
and the interaction between lipsome that mimicking either bacterial membrane or human cell 
membrane was characterized by SAXS. 
 
4.3.1. SEM characterization 
 
FE-SEM was used to characterize the morphology of bacteria before and after their treatment 
by the hydrophilic and cationic polymers. Figure 3.8 shows the SEM image of E.coli (A), E.coli 




Figure 4.8 The SEM image of E.coli only (A), E.coli treated by P4MVP28 (B), E.coli treated by 




Based on the SEM observation, bacteria treated by inactive P4MVP28 kept almost the same 
morphology as the control bacteria without any treatment. Their surfaces were relatively smooth 
and the cells were basically intact. However, for bacteria treated by the antimicrobial active 
P4MVP58 and tri-P4MVP63, their cell morphology has changed a lot. Rupture of the cell 
surface was clearly observed. Some bacteria were even totally destroyed. Those results suggest 
that P4MVP58 and tri-P4MVP63 killed the bacteria by disrupting the integrity of cell surface, 
specifically the cell membrane.  
 
The cell morphology of S. aureus before and after being treated by the hydrophilic and 
cationic polymers was also characterized by FE-SEM. Figure 3.9 shows that the SEM image of 
S. aurues (A), S. aureus treated by P4MVP28 (B), S. aureus treated by P4MVP58 (C), and S. 
aureus treated by tri-P4MVP63 (D), respectively.  
 
 
Figure 4.9 The SEM image of S.aureus only (A), S.aureus treated by P4MVP28 (B), S.aureus 




As we can see from those pictures, the S. aureus bacterial surface morphology didn’t change 
much even thought all those polymers were highly active for S. aureus. This observation makes 
sense when we realize that those polymers kill S. aureus by disrupting their cell membrane, not 
their cell wall that covers the membrane. Even though the cell membrane has been damaged, we 
can’t see the change by SEM since it is covered by the thick and dense exterior cell wall.  
 
4.3.2. SAXS characterization 
 
Small unilamellar vesicles (SUVs) comprised of DOPG/DOPE=20/80 were used as first-order 
model membranes for Gram-negative bacteria. Their self-assemblies with polymers were 
examines by SAXS. The scattering profile of the self-assemblies formed between SUV 
(DOPG/DOPE=20/80) and inactive P4MVP28 was shown in Figure 3.10A. There were two 
phases that can be indentified from this figure, one was a lamellar phase, with q position of each 
scattering peak satisfied ratio of 1:2:3:4; the other one was a hexagonal phase, with q position 
each scattering peak satisfied ratio of 1:√3:2:√7:3:√12:√13. The hexagonal structure, i.e., the 2D 
honey-comb-like structure of the co-assembled membrane and membrane-active antibiotics, was 
believed to play critical roles on the antimicrobial activities of those antibiotics.65,66 P4MVP28 
can partially induce SUVs to form hexagonal phase, but the lamellar phase was the main phase 
since it had stronger scattering intensity. This explained why P4MVP28 has very low 
antimicrobial activity.  
 
When P4MVP58 self-assembled with SUV, a pure hexagonal phase was formed, as shown in 
Figure 3.10B. No lamellar phase was observed. This also explained why P4MVP58 was very 
active to E.coli and why it was much more active than P4MVP28. The q position of the first 
scattering peak can be read from the figure q1,0=0.1129Å
-1, so unit cell parameter of this 
hexagonal structure is a =4π/(q1,0√3) = 6.43nm. Similar to P4MVP58, the antimicrobial active 
tri-P4MVP63 also induced the lipid of SUV to form a pure hexagonal phase, as shown in Figure 
3.10C. The q1,0 and a was determined to be 0.1116Å




Figure 4.10 SAXS characterization of self
and P4MVP28 (A), P4MVP58 (B), 
 
The self-assemblies of amphiphilic inactive P4EVP 28 with SUVs were also examined by 
SAXS (Figure 3.10D). As we can see from this figure, P4EVP induced the SUVs
lamellar phase and hexagonal phase, which was very similar to the structure formed between 
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-assemblies formed by SUV (
tri-P4MVP63 (C) and P4EVP28 (D). 
 
DOPG/DOPE=20/80) 
 to form both 
 
P4MVP28 and SUVs. This observation explained nicely why both P4MVP28 and P4EVP28 
were inactive.  
 
To understand why polymers can selectively kill bacteria, instead of human red blood cell, 
SUVs with the lipid composition (DOPG/DOPC=20/80) mimicking 
prepared and their self-assembly with polymers were examined by SAXS. The scattering profile 
of self-assembly formed by SUV (DOPG/DOPC=20/80) and P4MVP58 was shown in Figure 
3.11A. Only a very weak lamellar scattering was identified, in
loosely attached to the liposomes. This also indicates that the interaction between SUV 
(DOPG/DOPC=20/80) and P4MVP58 was very weak. So the polymers didn’t damage the human 
red blood cells.  
Figure 4. 11 SAXS characterization of self
(DOPG/DOPC=20/80) (A) and SUV (
 
It has been previously reported that a minimum PE content was required in order to form a 
hexagonal phase. We hereby pr
the lipid composition lies between bacterial membranes (
membranes (PG/PC=20/80) to get a general idea about what was the minimum PE content and 
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RBC
dicating that the P4MVP58 only 
-assemblies formed by P4MVP58 and SUV 
DOPG/DOPE/DOPC=20/50/30) (B)
epared a tertiary liposome (DOPG/DOPE/DOPC=20/50/30) with 
DOPG/DOPE=20/80) 






what would happen to those intermediate PE-containg liposome when interacted with polymers. 
The scattering profile of self-assembly formed by SUV (DOPG/DOPE/DOPC=20/50/30) and 
P4MVP58 was shown in figure 3.11B. Only lamellar structure was formed, indicating that the 
DOPE content was not high enough to form the hexagonal phase. So the minimum PE content is 
between 50-80%.  The lamellar phase formed by this liposome was much more obvious than that 
formed by SUV (DOPG/DOPC=20/80), suggesting that even though the DOPE content was not 
high enough to form the hexagonal phase, it did facilitate the interaction between liposome and 
polymers.  
 
4.3.3. Electron density reconstruction 
 
As discussed above, both P4MVP58 and tri-P4MVP63 were able to induce SUV 
(DOPG/DOPE=20/80) to form pure hexagonal phases, which makes the reconstruction of the 
electron density maps possible.  
For the self-assembly formed by P4MVP58 and SUV (PG/PE=20/80), the q position and 
intensity of each peak Iint(q) can be read from Figure 3.10B, and the amplitude Ah,k of each peak 
can be calculated according to equation 3.3. The sign of the amplitude Ah,k depended on the 
phase choice. The best acceptable phase choice was (+--++++), according to the phasing criteria 
developed by Turner and Gruner.62 The q position, Iint(q), multiplicity m, and Ah,k were listed in 
table 4.2. 
 
Table 4. 2 Summary of q, Iint(q), m and Ah,k for self-assembly of P4MVP58 and PG/PE=20/80. 
h,k q (Å-1) Iint(q) m (Ah,k)
2 Ah,k 
1,0 0.112867 26899.8 6 57.11258 7.557286 
1,1 0.190134 850.592 6 5.12495 -2.26384 
2,0 0.225306 732.316 6 6.195734 -2.48912 
2,1 0.299018 58.9059 12 0.438907 0.6625 
3,0 0.33868 185.34 6 3.543211 1.882342 
2,2 0.391064 65.2978 6 1.664344 1.290094 
1,3 0.406592 62.0349 12 0.854619 0.924456 
 
 
All the Ah,k were plugged into equation 3.4
plotted in Mathematica. The electron density of lipid head and tail was known to be 
and 0.30 e/Å3, respectively.75
c=0.0086. The absolute electron density was then plotted by 
3.12. 
 
Figure 4.12 Electron density reconstruction 
(PG/PE=20/80). (A) 1-D electron density along the X
map; (C) 3-D electron density surface map; (D) The model for the self
hydrophilic polymers and lipids.
 
Figure 3.12A showed the 1
unit cell number (actual length
was the electron density of lipid hydrocarbon tail. The value
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, and the relative electron density map 
 Plug those known value into equation 3.5, we obtained 
Mathematica
for self-assembly formed by P4MVP58 and SUVs 
-axis; (B) 2-D electron density contour 
-assembly between linear 
 
-dimension (1-D) electron density along the X





, as shown in Figure 
 
-axis. X-axis is the 
e/Å3, which 
3 correlated to the 
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electron density of lipid head. And the highest value electron density was 0.66e/Å3 and it was 
located at the center of each unit cell. The high electron density was attributed to the iodide ion 
absorbed to the polymers. The 2-D contour map (Figure 3.12B) and 3-D surface map (Figure 
3.12C) clearly showed that the highest electron density was located at the center of each unit cell. 
The rim ρ=0.54e/Å3 was separated from the center by a trough with ρ=0.44e/Å3 and each unit 
cell was separated by a valley with ρ=0.30e/Å3. So the picture of how linear hydrophilic 
polymers and lipids were arranged was now clear: Lipid heads were re-organized to form a 
hydrophilic pore, and each pore was filled by water and polymers. Pores were separated from 
each other by lipid hydrocarbon tails (Figure 3.12D). Unit cells were arranged into a 2-D 
hexagonal structure.  
 
For the self-assembly formed between tri-P4MVP63 and SUV (PG/PE=20/80), the same 
method was used to reconstruct the electron density. The q position, Iint(q), m and Ah,k were listed 
in table 4.3 
 
Table 4. 3 Summary of q, Iint(q),m and Ah,k for self-assembly of tri-P4MVP63 and PG/PE=20/80. 
h,k q (Å-1) Iint(q) m (Ah,k)
2 Ah,k 
1,0 0.111557 23360.4 6 48.45322 6.960835 
1,1 0.189011 760.749 6 4.529646 -2.1283 
2,0 0.222125 713.423 6 5.866658 -2.42212 
2,1 0.297895 58.67 12 0.433872 0.658689 
3,0 0.336809 158.077 6 2.988717 1.728791 
2,2 0.386761 63.5946 6 1.585457 1.259149 
1,3 0.402289 61.9227 12 0.835112 0.913845 
 
Plug all those Ah,k into equation 3.4, and ρlipid head=0.54e/Å
3 and ρlipid tail =0.30e/Å
3 into 
equation 3.5, we can get a=0.385, b=0.0086 and the absolute electron density was then plotted 
by Mathematica, as shown in Figure 3.13. 
 
Similar to the result found about P4MVP58, all 1-D plot (Figure 3.13A), 2-D contour map 
(Figure 3.13B) and 3-D surface map (Figure 3.13C) clearly showed that the highest electron 
 
density was located at the center of each unit cell. The rim 
center by a trough with ρ=0.43
So the same model of how branched hydrophilic polymers and lipids were arranged was 
obtained: Lipid heads were re
water and hydrophilic branched polymers. Pores were separated from each other by lipid 
hydrocarbon tails (Figure 3.13D). Unit cells were arranged into a 2
 
Figure 4.13 Electron density reconstruction for self
(PG/PE=20/80). (A) 1-D electron density along the X
map; (C) 3-D electron density surface map; (D) The model for the self






e/Å3 and each unit cell was separated by a valley with 
-organized to form a hydrophilic pore, and each pore was filled by 
-D hexagonal structure. 
-assembly formed by tri
-axis; (B) 2-D electron density contour 
 








CHAPTER 5 CONCLUSION AND OUTLOOK 
 
In this work, we successfully synthesized linear amphiphilic, linear hydrophilic and branched 
hydrophilic polymers with systematically varied microstructures. Their biological activity and 
antimicrobial mechanism were evaluated and investigated. We show that the hydrophilic and 
cationic P4MVP polymers can be very active when they have the right chain sizes. Those 
hydrophilic polymers generally have very low toxicity and their antimicrobial selectivity is 
excellent. They have a much larger space to improve the selectivity than the amphiphilic and 
cationic polymers, whose selectivity is usually limited by their toxicity. The antimicrobial 
activity and selectivity of hydrophilic polymers can be easily adjusted by controlling their chain 
sizes. Large polymers are active for both gram-negative and gram-positive bacteria, while small 
polymers selectively kill gram-positive bacteria. As a result, polymers with double selectivity 
can be easily synthesized. On the other hand, both linear and branched polymers can be similarly 
active when their branches are long enough. However, they may have different antimicrobial 
performance if the size of branches is small. Linear polymers are generally more active than 
branched polymers. The reason is unknown yet, but may have something to do with the degree of 
freedom to change their morphology when come to interact with bacteria membrane. The 
antimicrobial mechanism study shows that the hydrophilic and cationic polymers are also 
membrane-active antimicrobials. They can remodel the bacterial membranes into a 2D inverted 
hexagonal phase, i.e. damaging the integrity of bacterial membrane by forming pores, which 
further leads to the death of bacteria. 
 
The toxicity reported here is only limited to the hemolysis, but the toxicity against other types 
of mammalian cells is unknown. It should be noted that HC50 is a common standard widely used 
to characterize the toxicity of new antibiotic design, but further studies of the toxicity against 
other types of mammalian cells are needed to future clinical trials. Moreover, the antimicrobial 
mechanism, specifically the dependency on sizes, microstructures, and amphiphilicity needs 
further investigation. So our future work is to continue studying the toxicity of those hydrophilic 
polymers against other animal cells. In vivo study may be conducted, if experimental condition 
allows, to examine the distribution and metabolism of our polymeric SMAMPs in animal 
models. Besides SEM and SAXS, other characterization techniques, such as confocal, ITC and 
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TEM, will also be used to get a better understanding about their antimicrobial mechanism with 
molecular details.  
The increased activity with the increase of polymer size could come from either the increased 
chain length or the increased charge density. To better understand the effect of chain length and 
charge density, we are going to replace part of P4MVP with an hydrophilic but non-charged 
polymer segment, Poly(hydroxyethylmethacrylate) for example, to study the antimicrobial 
activity of polymers with the same size but different charge density and polymers with the same 
charge density but different size. The effect charge distribution (i.e. at ends or in the middle) will 
also be investigated.  
 
We show strongly in this thesis work that hydrophilic and cationic polymers are very 
promising candidates for next generation of antibiotics. We hope that more and more research 
groups in the SMAMP community will realize the importance of developing hydrophilic 
polymers, and more hydrophilic polymers with excellent antimicrobial activity and 
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